Patents by Inventor Subhas Bhowmick
Subhas Bhowmick has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11304898Abstract: A method of treating patients suffering from carcinoma of intrahepatic or extra hepatic bile duct or gall bladder which is locally advanced or metastatic, by intravenously administering to the patient, paclitaxel in the form of a nanodispersion. The nanodispersion comprises particles with a mean particle size less than 300 nm and is free of polyoxyethylated castor oil and free of a protein.Type: GrantFiled: June 8, 2016Date of Patent: April 19, 2022Assignee: SUN PHARMA ADVANCED RESEARCH COMPANY LTDInventors: Wen Wee Ma, Alex Adjei, Lynne Bui, Ronald Harning, Ajay Khopade, Subhas Bhowmick, Natarajan Arulsudar, Narendra Lakkad
-
Patent number: 10272206Abstract: The present invention provides a sterile solution comprising leuprolide acetate in a pharmaceutically acceptable vehicle, wherein solution is present as a reservoir in a multiple dose pen injection device, the device being adapted to subcutaneously inject a portion of the said reservoir in a single daily dose and further being adapted to provide multiple portions of solution said while the reservoir remains sterile.Type: GrantFiled: May 17, 2017Date of Patent: April 30, 2019Assignee: Sun Pharmaceutical Industries LimitedInventors: Alex George, Prashant Kane, Subhas Bhowmick
-
Patent number: 10098813Abstract: The present invention relates to a method for enabling hospitals or clinics to administer a dose of a drug to patients in need thereof while avoiding steps of manipulation, dilution, reconstitution, dispensing, sterilization, transfer, handling or compounding before intravenous administration. The present invention further relates to a perfusion system comprising different sets of perfusion containers, each container comprising a ready-to-infuse, stable, sterile, aqueous perfusion solution of a drug, wherein the set of perfusion containers alone or in combination provides for direct intravenous administration of a desired dose of the drug to a patient in need thereof, such that the delivered dose is equal to or within ±5% of the calculated dose.Type: GrantFiled: September 2, 2015Date of Patent: October 16, 2018Assignee: SUN PHARMACEUTICAL INDUSTRIES LIMITEDInventors: Samarth Kumar, Prashant Kane, Balaram Subhas Bhowmick, Kirti Ganorkar, Nishit Patel, Anilrao Ashish Dubewar, Mukeshbhai Umeshkumar Patel
-
Publication number: 20180140549Abstract: A method of treating patients suffering from carcinoma of intrahepatic or extra hepatic bile duct or gall bladder which is locally advanced or metastatic, by intravenously administering to the patient, paclitaxel in the form of a nanodispersion. The nanodispersion comprises particles with a mean particle size less than 300 nm and is free of polyoxyethylated castor oil and free of a protein.Type: ApplicationFiled: June 8, 2016Publication date: May 24, 2018Applicant: SUN PHARMA ADVANCED RESEARCH COMPANY LTDInventors: Wen Wee MA, Alex ADJEI, Lynne BUI, Ronald HARNING, Ajay KHOPADE, Subhas BHOWMICK, Natarajan ARULSUDAR, Narendra LAKKAD
-
Publication number: 20170252517Abstract: The present invention provides a sterile solution comprising leuprolide acetate in a pharmaceutically acceptable vehicle, wherein solution is present as a reservoir in a multiple dose pen injection device, the device being adapted to subcutaneously inject a portion of the said reservoir in a single daily dose and further being adapted to provide multiple portions of solution said while the reservoir remains sterile.Type: ApplicationFiled: May 17, 2017Publication date: September 7, 2017Applicant: Sun Pharmaceutical Industries LimitedInventors: Alex GEORGE, Prashant KANE, Subhas BHOWMICK
-
Patent number: 9656023Abstract: The present invention provides a sterile solution comprising leuprolide acetate in a pharmaceutically acceptable vehicle, wherein solution is present as a reservoir in a multiple dose pen injection device, the device being adapted to subcutaneously inject a portion of the said reservoir in a single daily dose and further being adapted to provide multiple portions of solution said while the reservoir remains sterile.Type: GrantFiled: February 4, 2014Date of Patent: May 23, 2017Assignee: Sun Pharmaceutical Industries LimitedInventors: Alex George, Prashant Kane, Subhas Bhowmick
-
Publication number: 20160058663Abstract: The present invention relates to a method for enabling hospitals or clinics to administer a dose of a drug to patients in need thereof while avoiding steps of manipulation, dilution, reconstitution, dispensing, sterilization, transfer, handling or compounding before intravenous administration. The present invention further relates to a perfusion system comprising different sets of perfusion containers, each container comprising a ready-to-infuse, stable, sterile, aqueous perfusion solution of a drug, wherein the set of perfusion containers alone or in combination provides for direct intravenous administration of a desired dose of the drug to a patient in need thereof, such that the delivered dose is equal to or within ±5% of the calculated dose.Type: ApplicationFiled: September 2, 2015Publication date: March 3, 2016Applicant: SUN PHARMACEUTICAL INDUSTRIES LIMITEDInventors: Samarth KUMAR, Prashant KANE, Balaram Subhas BHOWMICK, Kirti GANORKAR, Nishit PATEL, Anilrao Ashish DUBEWAR, Mukeshbhai Umeshkumar Patel
-
Publication number: 20140213984Abstract: The present invention provides a sterile solution comprising octreotide acetate in a pharmaceutically acceptable vehicle, wherein solution is present as a reservoir in a multiple dose pen injection device, the device being adapted to subcutaneously inject a portion of the said reservoir in multiple daily doses and further being adapted to provide multiple portions of the said solution, while the reservoir remains sterile.Type: ApplicationFiled: April 1, 2014Publication date: July 31, 2014Applicant: Sun Pharmaceutical Industries LimitedInventors: Shantaram PAWAR, Alex GEORGE, Prashant KANE, Subhas BHOWMICK
-
Publication number: 20140155835Abstract: The present invention provides a sterile solution comprising leuprolide acetate in a pharmaceutically acceptable vehicle, wherein solution is present as a reservoir in a multiple dose pen injection device, the device being adapted to subcutaneously inject a portion of the said reservoir in a single daily dose and further being adapted to provide multiple portions of solution said while the reservoir remains sterile.Type: ApplicationFiled: February 4, 2014Publication date: June 5, 2014Applicant: SUN PHARMACEUTICALS LTD.Inventors: Alex GEORGE, Prashant KANE, Subhas BHOWMICK
-
Publication number: 20130303453Abstract: The present invention provides a sterile solution comprising octreotide acetate in a pharmaceutically acceptable vehicle, wherein solution is present as a reservoir in a multiple dose pen injection device, the device being adapted to subcutaneously inject a portion of the said reservoir in multiple daily doses and further being adapted to provide multiple portions of the said solution, while the reservoir remains sterile.Type: ApplicationFiled: May 8, 2013Publication date: November 14, 2013Inventors: Shantaram PAWAR, Alex GEORGE, Prashant KANE, Subhas BHOWMICK
-
Publication number: 20130288968Abstract: The present invention provides a sterile solution comprising leuprolide acetate in a pharmaceutically acceptable vehicle, wherein solution is present as a reservoir in a multiple dose pen injection device, the device being adapted to subcutaneously inject a portion of the said reservoir in a single daily dose and further being adapted to provide multiple portions of solution said while the reservoir remains sterile.Type: ApplicationFiled: April 30, 2013Publication date: October 31, 2013Inventors: Alex GEORGE, Prashant KANE, Subhas BHOWMICK
-
Publication number: 20130064870Abstract: The dry powder inhalation composition comprising (1) salmeterol xinafoate having mean particle size in range of 2.0?-6? microns and a tapped density in the range of 0.20 g·cm?3 to 0.45 g·cm?3 and (2) optionally, one or more other active ingredients and pharmaceutically acceptable carrier.Type: ApplicationFiled: May 13, 2011Publication date: March 14, 2013Applicant: SUN PHARMA ADVANCED RESEARCH COMPANY LIMITEDInventors: Subhas Bhowmick, Prashant Kane, Ganesh S, Tarun Patel, Swapnil Chudiwal
-
Publication number: 20070112041Abstract: A nicardipine hydrochloride injection composition comprising sorbitol in amounts sufficient to stabilize the injection preparation and a physiologically and pharmaceutically acceptable buffer, in an amount effective to maintain the pH of the composition at about 3.0 to about 4.5.Type: ApplicationFiled: November 14, 2006Publication date: May 17, 2007Inventors: Subhas Bhowmick, Ajay Khopade, Sharmila Ganesh